Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
20 earlier
penile metastasis from prostate adenocarcinoma a case report and review of the literature
Original title: “Penile metastasis from prostate adenocarcinoma: A case report and review of the literature.”
clinical characteristics and outcomes of acute intermittent porphyria insights from the european porphyria registry
Original title: “Clinical Characteristics and Outcomes of Acute Intermittent Porphyria: Insights From the European Porphyria Registry.”
More patients on Eli Lilly’s tirzepatide lost over 5% of their lean mass versus those on Novo Nordisk’s semaglutide, according to a study that has yet to be peer reviewed.
Original title: “Novo may have muscle advantage over Lilly in weight-loss race: preprint”
cryo em reveals structural variability of apolipoprotein a i amyloid fibrils across organs mutations and clinical presentations
Original title: “Cryo-EM reveals structural variability of apolipoprotein A-I amyloid fibrils across organs, mutations, and clinical presentations.”
pten restrains shh medulloblastoma growth through cell autonomous and nonautonomous mechanisms
Original title: “PTEN restrains SHH medulloblastoma growth through cell autonomous and nonautonomous mechanisms.”